Case-03: Marketing

Introducing Past Case Studies using Data from MDV Database.

Case Study (Marketing)

Switch Rates, Time-to-switch, and Switch Patterns of Antiretroviral Therapy in People Living with Human Immunodeficiency Virus in Japan, using a Hospital-claim Database

case_studies03_img_02.png

Ruzicka DJ, Kuroishi N, Oshima N, et al. Switch rates, time-to-switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital-claim database. BMC Infect Dis. 2019;19(1):505. Published 2019 Jun 10. doi:10.1186/s12879-019-4129-6

Introduction

  • Antiretroviral therapy (ART) contributes to extend HIV patient’s life expectancy
  • Combination of the following medications have been the recommended regimen in Japanese guidelines:
    • Backbone therapy: 2 nucleoside reverse transcriptase inhibitors
    • Add on of an anchor drug among:
      • a.Integrase strand transfer inhibitors (INSTIs)
      • b.Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
      • c.Protease inhibitors (PIs)
      • d.Entry inhibitors (Els)

Objectives of Study

To understand the switch rates and time-to-switch of ART regimens in patients with HIV between 2008 to 2016 in Japan

Study Design and Criteria

Study Design: Retrospective Observational Database Study.

Target Period: April 2008 - December 2016

case_studies03_img_03.png

Definition of Regimen Switch

Regimen switch is referring to only when adopting anchor drug classes.
Change in anchor drug classes within 28 days of a different anchor drug is considered a change in regimen.

case_studies03_img_04.png

Patient Disposition

case_studies03_img_05.png

Distributions of anchor drug class and backbone in the ART regimens by year

case_studies03_img_06.png case_studies03_img_07.png

Switching Patterns and Timing

Switching patterns of anchor drug class in ART regimens by switching timing from 2011 to 2016

case_studies03_img_08.png

Time-to-switch

Time-to-switch of ART regimens according to anchor drug class from 2011 to 2016

case_studies03_img_09.png

Conclusion

  • An ART regimen including INSTI maintained a low switch rate for long duration.
  • The major switch was seen mainly from NNRTI or PI to INSTI for secondary treatment suggesting INSTI is rather a tentative treatment approach for HIV patients

Service used for the Case Study:

Abbreviation in Article

  • 3TCLamivudine
  • ABCAbacavir
  • AEAdverse event
  • ARTAntiretroviral therapy
  • ATV/rAtazanavir/ritonavir
  • AZTZidovudine
  • CIConfidence interval
  • DTGDolutegravir
  • EFVEfavirenz
  • EIEntry inhibitor
  • FTCEmtricitabine
  • HIVHuman immunodeficiency virus
  • HRHazard ratio
  • ICD-10The International Statistical Classification of Diseases and Related Health Problems 10th Revision
  • INSTIIntegrase strand transfer inhibitor
  • NNRTINon-nucleoside reverse transcriptase inhibitor
  • NRTINucleoside reverse transcriptase inhibitor
  • PIProtease inhibitor
  • PLWHPeople living with human immunodeficiency virus
  • TAFTenofovir alafenamide fumarate
  • TDFTenofovir disoproxil fumarate

For More Information, Please Contact Us Here

Contact Us

About Japanese Healthcare System

What you need to know about the healthcare system in Japan before using the data.

Read More Contact Us

Service

Data-set Provision

Read More

Web Tools

Read More
SECURITY POLICY PRIVACY POLICY ANONYMOUSLY PROCESSED INFORMATION ABOUT SITE
© Medical Data Vision Co., Ltd. All Rights Reserved.
© Medical Data Vision Co., Ltd. All Rights Reserved.